Insights

Targeted Oncology Privately-held biotech focusing on novel targeted cancer therapies: potential collaboration opportunities with partners seeking precision medicine platforms or co-development deals aimed at transporter-overexpressing tumors.

Resource-Constrained Small team (2–10 employees) with limited internal funding (revenue under $1M; $2M funding): favorable for strategic partnerships, licensing arrangements, or sponsored research agreements to scale without heavy internal overhead.

Innovation Lever Technology hinges on exploiting over-expressed amino acid transporters; opportunity to present analytics, assay development services, or biomarker validation support to accelerate preclinical target validation and companion diagnostic work.

Digital Presence Active web and cloud-enabled tech stack (Squarespace, WordPress, Google Cloud) suggests openness to digital collaboration tools, data-sharing platforms, or joint marketing/academic partnership initiatives with streamlined onboarding.

Funding Path Recent funding of $2M alongside revenue under $1M indicates readiness for non-dilutive partnerships or milestone-driven licensing deals, and potential for investor-backed co-development programs to de-risk early-stage programs.

Similar companies to Quadriga BioSciences, Inc.

Quadriga BioSciences, Inc. Tech Stack

Quadriga BioSciences, Inc. uses 8 technology products and services including Squarespace, WordPress, OneTrust, and more. Explore Quadriga BioSciences, Inc.'s tech stack below.

Quadriga BioSciences, Inc.'s Email Address Formats

Quadriga BioSciences, Inc. uses at least 2 email formats:
Quadriga BioSciences, Inc. Email FormatsExamplePercentage
First.Last@quadrigabiosciences.comJohn.Doe@quadrigabiosciences.com
71%
FLast@quadrigabiosciences.comJDoe@quadrigabiosciences.com
29%

Frequently Asked Questions

What is Quadriga BioSciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Quadriga BioSciences, Inc.'s official website is quadrigabiosciences.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Quadriga BioSciences, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Quadriga BioSciences, Inc.'s annual revenue is estimated to be <$1M.

What is Quadriga BioSciences, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Quadriga BioSciences, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Quadriga BioSciences, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Quadriga BioSciences, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Chief Financial Officer: W. F. and Board Member: K. L. Explore Quadriga BioSciences, Inc.'s employee directory with LeadIQ.

What industry does Quadriga BioSciences, Inc. belong to?

Minus sign iconPlus sign icon
Quadriga BioSciences, Inc. operates in the Biotechnology Research industry.

What technology does Quadriga BioSciences, Inc. use?

Minus sign iconPlus sign icon
Quadriga BioSciences, Inc.'s tech stack includes Squarespace, WordPress, OneTrust, Webpack, Shopify, Google Workspace, Google Cloud and jQuery Migrate.

What is Quadriga BioSciences, Inc.'s email format?

Minus sign iconPlus sign icon
Quadriga BioSciences, Inc.'s email format typically follows the pattern of First.Last@quadrigabiosciences.com. Find more Quadriga BioSciences, Inc. email formats with LeadIQ.

How much funding has Quadriga BioSciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Quadriga BioSciences, Inc. has raised $2M in funding. The last funding round occurred on Jan 01, 2018.

When was Quadriga BioSciences, Inc. founded?

Minus sign iconPlus sign icon
Quadriga BioSciences, Inc. was founded in 2015.
Quadriga BioSciences, Inc. logo

Quadriga BioSciences, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Quadriga BioSciences, Inc. is a privately held biotechnology company focused on developing targeted cancer therapies. The firm aims to exploit a biological vulnerability observed in many aggressive cancers, where tumor cells over-express specific amino acid transporters on their surfaces to support rapid growth, and it designs molecules intended to target those cancer cells selectivity. Based in Los Altos, California, the company operates within the biotechnology research sector and pursues safer and more effective treatment options for cancer patients. The organization appears to be a small team, positioned to advance early-stage therapeutic concepts through its proprietary approach. A recent development note indicates ongoing advancement in its targeted cancer therapy program, reflecting continued progress in its specialized research area.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
2-10

Section iconFunding & Financials

  • $2M

    Quadriga BioSciences, Inc. has raised a total of $2M of funding over 2 rounds. Their latest funding round was raised on Jan 01, 2018 as a Venture Round.

  • <$1M

    Quadriga BioSciences, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.